Loading…

Ascites in the Course of Plasma Cell Myeloma Complicated by AL Amyloidosis

A 60-year-old Caucasian male with plasma cell myeloma (PCM) immunoglobulin G (IgG) kappa, International Staging System stage 3, diagnosed 5 months ago, was admitted to the department of hematology due to progression of the disease. He had completed three cycles of chemotherapy comprising bortezomib,...

Full description

Saved in:
Bibliographic Details
Published in:Turkish journal of haematology 2018-03, Vol.35 (1), p.71-72
Main Authors: Debski, Jakub, Usnarska-Zubkiewicz, Lidia, Kapelko-Słowik, Katarzyna, Pawluś, Aleksander, Zaleska-Dorobisz, Urszula, Kuliczkowski, Kazimierz
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 60-year-old Caucasian male with plasma cell myeloma (PCM) immunoglobulin G (IgG) kappa, International Staging System stage 3, diagnosed 5 months ago, was admitted to the department of hematology due to progression of the disease. He had completed three cycles of chemotherapy comprising bortezomib, thalidomide, and dexamethasone; one cycle comprising vincristine, doxorubicin, and dexamethasone; and two cycles comprising lenalidomide and dexamethasone, without any clinically significant response. Three weeks before visiting the hospital, the patient also started complaining of progressive weakness, impaired respiratory function, and abdominal distension; an abdominal ultrasound at the time revealed hepatosplenomegaly with ascites, most likely associated with portal hypertension and protein disturbance, which initially he tolerated very well.
ISSN:1300-7777
1308-5263
DOI:10.4274/tjh.2016.0262